Literature DB >> 11861913

The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR.

Jean M Nussbaum1, Shobha Gunnery, Michael B Mathews.   

Abstract

Cytoskeletal proteins are associated with actin in the microfilaments and have a major role in microfilament assembly and function. The expression of some of these proteins has been implicated in cell growth and transformation. Specifically, the 3'-untranslated regions (3'-UTRs) of tropomyosin, troponin and cardiac actin can induce muscle cell differentiation and appear to function as tumor suppressors. These RNA sequences are predicted to fold to form secondary structures with extended stretches of duplex. We show that the 3'-UTRs of the cytoskeletal mRNAs interact with the RNA-binding domain of the RNA-activated protein kinase PKR. Correspondingly, these RNAs activate PKR in vitro and inhibit globin translation in the rabbit reticulocyte lysate translation system. These data are consistent with a mechanism whereby PKR mediates the differentiation- and tumor-related actions of the cytoskeletal 3'-UTR sequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861913      PMCID: PMC101232          DOI: 10.1093/nar/30.5.1205

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

2.  Interactions between double-stranded RNA regulators and the protein kinase DAI.

Authors:  L Manche; S R Green; C Schmedt; M B Mathews
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  Activation of the double-stranded RNA-dependent eIF-2 alpha kinase by cellular RNA from 3T3-F442A cells.

Authors:  J Li; R A Petryshyn
Journal:  Eur J Biochem       Date:  1991-01-01

4.  Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function.

Authors:  K H Mellits; M Kostura; M B Mathews
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  cDNA sequence, tissue-specific expression, and chromosomal mapping of the human slow-twitch skeletal muscle isoform of troponin I.

Authors:  R Wade; R Eddy; T B Shows; L Kedes
Journal:  Genomics       Date:  1990-07       Impact factor: 5.736

6.  Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation.

Authors:  F Rastinejad; H M Blau
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA.

Authors:  G L Prasad; R A Fuldner; R Braverman; E McDuffie; H L Cooper
Journal:  Eur J Biochem       Date:  1994-08-15

8.  Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin.

Authors:  F Rastinejad; M J Conboy; T A Rando; H M Blau
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

9.  Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.

Authors:  G L Prasad; R A Fuldner; H L Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

Authors:  E F Meurs; J Galabru; G N Barber; M G Katze; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  23 in total

1.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

2.  Potential role for snoRNAs in PKR activation during metabolic stress.

Authors:  Osama A Youssef; Sarah A Safran; Takahisa Nakamura; David A Nix; Gökhan S Hotamisligil; Brenda L Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

3.  STAU1 binding 3' UTR IRAlus complements nuclear retention to protect cells from PKR-mediated translational shutdown.

Authors:  Reyad A Elbarbary; Wencheng Li; Bin Tian; Lynne E Maquat
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

4.  A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

5.  ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing.

Authors:  Yongzhan Nie; Li Ding; Peter N Kao; Robert Braun; Jing-Hua Yang
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 6.  Regulation of innate immunity through RNA structure and the protein kinase PKR.

Authors:  Subba Rao Nallagatla; Rebecca Toroney; Philip C Bevilacqua
Journal:  Curr Opin Struct Biol       Date:  2010-12-08       Impact factor: 6.809

7.  Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins.

Authors:  Stephanie J Child; Laura K Hanson; Crystal E Brown; Deanna M Janzen; Adam P Geballe
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Analysis of PKR structure by small-angle scattering.

Authors:  Jennifer VanOudenhove; Eric Anderson; Susan Krueger; James L Cole
Journal:  J Mol Biol       Date:  2009-02-14       Impact factor: 5.469

Review 9.  RNA sensors: novel regulators of gene expression.

Authors:  Raymond Kaempfer
Journal:  EMBO Rep       Date:  2003-11       Impact factor: 8.807

10.  Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.

Authors:  Roshan J Thapa; Shoko Nogusa; Peirong Chen; Jenny L Maki; Anthony Lerro; Mark Andrake; Glenn F Rall; Alexei Degterev; Siddharth Balachandran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.